Premium
Current status of immunosuppressive agents for solid organ transplantation in children
Author(s) -
Coelho Tracy,
Tredger Michael,
Dhawan Anil
Publication year - 2012
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/j.1399-3046.2012.01644.x
Subject(s) - medicine , transplantation , current (fluid) , organ transplantation , solid organ , intensive care medicine , immunosuppression , immunology , electrical engineering , engineering
Coelho T, Tredger M, Dhawan A. Current status of immunosuppressive agents for solid organ transplantation in children.
Pediatr Transplantation 2012: 16: 106–122. © 2012 John Wiley & Sons A/S. Abstract: Immunosuppression after organ transplantation is complex and ever evolving. Over the past two decades, newer immunosuppressive agents have been introduced with an aim to provide better patient and graft survival. Improved therapeutic strategies have been developed offering the option to use combinations of drugs with non‐overlapping toxicities. There are, however, only a few clinical studies with robust data to rationalize the use of these agents in children. This review will discuss the newer immunosuppressive agents used for solid organ transplant, their current status in post‐transplant management and prevention of allograft rejection.